Bacille Calmette-Guérin (BCG) lymphadenitis is the most common complication of BCG vaccination. It commonly occurs in infants aged <6 months involving ipsilateral axillary lymph nodes. We described BCG lymphadenitis in a 22-month-old boy presenting swelling of left supraclavicular lymph node that was confirmed by real-time polymerase chain reaction (PCR) and the multiplex PCR targeting the region of difference (RD).
Introduction
Although bacille Calmette-Guérin (BCG) vaccination has been accepted as an effective and safe protective measure against the disseminated disease and meningitis in childhood tuberculosis, various complications have been reported 1) . BCG lymphadenitis is one of the most common complication resulting from this vaccination and mostly presented with ipsilateral axillary lymphadenitis. BCG lymphadenitis may develop as early as two weeks after vaccination and disappear spontaneously within six months [1] [2] [3] . These characteristics could help for diagnosis and treatment of BCG lymphadenitis clinically. However, atypical clinical features may make it difficult to differentiate from tuberculous lymphadenitis, which necessitates the identification of the BCG strain with phase typing or gene analysis. We report a boy presenting supraclavicular lymphadenitis at 21 months after BCG Tokyo strain vaccination, which was confirmed by the real-time polymerase chain reaction (PCR) targeting the senX3-regX intergenic region (IR) and the multiplex PCR that targeted the region of difference 1 (RD1), RD8 and RD14.
Case report
A 22-month-old Korean boy presented with localized swelling of left supraclavicular area, which was developed 2 weeks ago, in December 2012.
The lesion was developed 2 weeks ago and there was no accompanying symptom such as fever, weight loss, and cough. He was born by cesarean and RD14, as previously described 4) . He was treated by repeated aspirations without anti-tuberculous medication, and recovered 3 months after the first aspiration.
Discussion
BCG lymphadenitis is a common local reaction of BCG vaccination. Incidence of BCG lymphadenitis varies depending on the vaccine strain, the technique of administration, the age of the recipient, and the dose administered, with the rate ranging from 0.1 to 5 per 1000 vaccinated children 5) . In Korea, the incidence rate of BCG lymphadenitis has been reported 0-6% 6) . There have been reports from many countries with an estimated incidence of <4/10,000 vaccinees younger than 1 year old 7, 8) .
After vaccination, the BCG strain starts multiplying rapidly at the site of inoculation and is later transported through the lymphatics to the regional lymph nodes, followed by the hematogenous dissemination of the BCG, resulting in creation of very small foci in different organs. This is called "normal BCG-itis" in the course of successful BCG vaccination 9) . Among these organs, slightly enlarged regional nodes are common after BCG vaccination, but are rarely noticeable unless searched for specifically. This subclinical lymphadenitis regresses spontaneously, is of no practical importance, and may not be regarded as a complication. However, there is no easy way to differentiate "normal" from "abnormal" and there is no . However, there is no convincing evidence that the use of anti-tuberculous medication either reduces the risk of suppuration or shortens the duration of healing. Surgical excision is definitively not recommended for non-suppurative cases because it requires general anesthesia which carries a risk to young children and infants 10) . In the case of suppuration, surgical treatment either by needle aspiration or by surgical excision could be undertaken. Though surgical excision is likely to be curative and will reduce the healing time, repeated needle aspiration has recently been advocated as not only diagnostic but also therapeutic procedure to avoid suppuration and prolonged drainage 8) .
In our case, clinical examination revealed supra- However, AdvanSure TB/NTM real-time PCR Kit has a high sensitivity (100%) to tuberculosis mycobacteria but a low sensitivity (55.6%) to nontuberculous mycobacteria, which mean that only the PCR method using this kit would not be enough for detecting nontuberculous mycobacteria 11) . In addition, considering that suspected tuberculous lymphadenitis patients without an identifiable tuberculous contact were subject to further investigations for differential diagnosis of M. bovis BCG, we performed the tar- tuberculosis complex members, enabling us to differentiate different strains belonging to the M. tuberculosis complex and making surveillance of speciesspecific disease suitable 13, 14) . This diagnostic method could help to confirm BCG lymphadenitis. Based on these results, we could treat the patient by repeated aspirations without anti-tuberculous medication.
In conclusion, atypically delayed presentation of BCG lymphadenitis could make the differential diagnosis from tuberculous lymphadenitis difficult. We 
